文献速递冠心病外科瓣膜外科

心脏手术患者深静脉血栓与肺栓塞的发生率、死亡率及费用

Deep Venous Thrombosis and Pulmonary Embolism in Cardiac Surgical Patients.
PubMed 文献 · Ann Thorac Surg · 2019-11-07

深静脉血栓和肺栓塞与死亡率升高相关(4.95%和14.8% vs 2.67%),且分别增加约12,308美元和13,879美元的医疗费用。肺栓塞是死亡的独立预测因素(调整OR 3.39,95%CI 2.74-4.18)。

要点

  • 心脏手术后深静脉血栓发生率为1.62%,肺栓塞为0.38%。
  • 深静脉血栓和肺栓塞患者死亡率分别为4.95%和14.8%,高于无血栓患者的2.67%。

核心结论

  • 心脏手术患者血栓栓塞相关死亡和经济负担显著,预防措施可能有益。

主要发现

  • 深静脉血栓发生率为1.62%,肺栓塞发生率为0.38%。
  • 深静脉血栓和肺栓塞患者更多为女性、年龄更大且合并症指数更高(P < .001)。
  • 深静脉血栓和肺栓塞患者死亡率分别为4.95%和14.8%,均高于无血栓患者的2.67%(P < .001)。
  • 调整基线差异后,深静脉血栓增加费用12,308美元,肺栓塞增加费用13,879美元。
  • 肺栓塞是死亡的独立预测因素(调整OR 3.39;95%CI 2.74-4.18)。

临床怎么用

  • 心脏手术患者应考虑血栓栓塞预防以改善医疗质量并降低医疗费用。
  • 未来需开展随机对照试验验证预防措施的获益。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Deep venous thrombosis and pulmonary embolism are life-threatening complications after surgery, warranting prophylaxis. However prophylaxis is not uniformly practiced among cardiac surgical patients. This study aimed to characterize the national incidence, mortality, and costs associated with thromboembolism after cardiac surgery. METHODS: The 2005 to 2015 National Inpatient Sample was used to identify all adult patients undergoing coronary artery bypass grafting or valve surgery. International Classification of Disease codes were used to identify patients with deep venous thrombosis and pulmonary embolism. RESULTS: Of approximately 3 million patients undergoing cardiac surgery, 1.62% developed deep venous thrombosis and 0.38% pulmonary embolism. Those with deep venous thrombosis and pulmonary embolism were more commonly women (33.2% and 36.2 vs 31.2%, P < .001), older (68.1 and 66.0% vs 65.7 years, P < .001), and had a higher Elixhauser comorbidity index (4.0 and 4.7 vs 3.7, P < .001). Deep venous thrombosis and pulmonary embolism were associated with increased mortality (4.95% and 14.8% vs 2.67%, P < .001). After adjustment for baseline differences, deep venous thrombosis was associated with an incremental increase in cost of $12,308, whereas pulmonary embolism was associated with $13,879 cost increase after cardiac surgery. Pulmonary embolism was an independent predictor of mortality (adjusted odds ratio, 3.39; 95% confidence interval, 2.74-4.18). CONCLUSIONS: The mortality and financial burden related to thromboembolism in cardiac surgery are significant. Prophylaxis may be indicated in cardiac surgery patients to improve quality of care and reduce healthcare costs. Future controlled randomized trials investigating the benefit of thromboembolism prophylaxis in cardiac surgery are warranted.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Khoury H, Lyons R, Sanaiha Y, et al. Deep Venous Thrombosis and Pulmonary Embolism in Cardiac Surgical Patients. Ann Thorac Surg. 2019. PMID: 31706868. doi:10.1016/j.athoracsur.2019.09.055

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。